Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2413 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

30 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ESCITALOPRAM 20MG TABLET Resolved 2020-08-20 2020-09-24 122717
TEVA-ESCITALOPRAM 20MG TABLET Resolved 2021-02-18 2021-03-18 134349
TEVA-ESCITALOPRAM 20MG TABLET Resolved 2022-09-30 2022-12-08 170779
TEVA-ESCITALOPRAM 10MG TABLET Resolved 2022-09-30 2022-12-02 170798
TEVA-ESCITALOPRAM 20MG TABLET Resolved 2022-12-22 2023-04-28 179183
TEVA-ESCITALOPRAM 20MG TABLET Resolved 2023-01-12 2023-04-28 180906
TEVA-ESCITALOPRAM 10MG TABLET Resolved 2023-06-08 2023-06-27 194141
TEVA-ESCITALOPRAM 10MG TABLET Resolved 2023-06-16 2023-06-27 195133
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2020-01-24 2021-03-11 104339
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2020-01-24 2021-01-01 104344
TEVA-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2020-05-08 2021-01-07 114424
TEVA-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2020-05-14 2021-07-22 115207
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2021-01-15 2021-02-11 131682
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2021-07-15 2021-08-13 142613
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2021-09-16 2021-10-07 145777
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-01-20 2022-04-21 153138
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-08-18 2022-10-29 167221
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-12-01 2023-07-05 176797
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-12-15 2023-10-04 178524
TEVA-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2023-06-16 2024-01-19 195052

Showing 1221 to 1240 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598

Showing 81 to 100 of 250